Healthcare
FNArena Windows (Sectors)
Introduction to FNArena Windows
FNArena Windows offers subscribers the option to investigate ASX-listed stocks against their peers. FNArena developed its own sector methodology which in our view overcomes many flaws and disadvantages connected with GICS sectors. Our system starts with three broad sector labels: COMMODITIES, FINANCIAL SERVICES and INDUSTRIALS. From here onwards subscribers can explore further through gradually narrowing branches. This is not investment advice, but simply another window on the Australian Stock Exchange to provide better insight and to assist FNArena subscribers while conducting their own market analysis.
Latest Stories
New research coverage on Sonic Healthcare suggests better times are ahead, supplemented by new technologies including artificial intelligence and genetic engineering
Jun 20 2025
A decline in Services revenue had led to another profit downgrade from Cochlear, but brokers look ahead to new product launches
Jun 19 2025
| ASX CODE | COMPANY NAME | LAST PRICE | 52WK HIGH | 52WK LOW | P/E | CONSENSUS TARGET |
|---|---|---|---|---|---|---|
| 4DX | 4DMEDICAL LIMITED | $0.25 | $0.70 | $0.23 |
$0.73 |
|
| ACL | 4DMEDICAL LIMITED | $2.81 | $3.86 | $2.32 |
$3.65 |
|
| ALC | ALCIDION GROUP LIMITED | $0.11 | $0.12 | $0.05 | 550.0 |
$0.11 |
| ARX | AROA BIOSURGERY LIMITED | $0.56 | $0.82 | $0.35 | 55.8 |
$0.81 |
| AVH | AVITA MEDICAL INC | $1.63 | $4.52 | $1.48 |
$2.70 |
|
| BIO | AVITA MEDICAL INC | $0.50 | $xx.xx | $xx.xx | xx.x | xx.xx |
| BMT | AVITA MEDICAL INC | $0.24 | $xx.xx | $xx.xx | xx.x | xx.xx |
| CAT | CATAPULT GROUP INTERNATIONAL LIMITED | $5.79 | $xx.xx | $xx.xx | xx.x | xx.xx |
| COH | COCHLEAR LIMITED | $304.56 | $xx.xx | $xx.xx | xx.x | xx.xx |
| CSL | CSL LIMITED | $238.24 | $xx.xx | $xx.xx | xx.x | xx.xx |
| CU6 | CSL LIMITED | $2.70 | $xx.xx | $xx.xx | xx.x | xx.xx |
| CUV | CSL LIMITED | $10.12 | $xx.xx | $xx.xx | xx.x | xx.xx |
| CVB | CURVEBEAM AI LIMITED | $0.07 | $xx.xx | $xx.xx | xx.x | xx.xx |
| CYC | CYCLOPHARM LIMITED | $0.92 | $xx.xx | $xx.xx | xx.x | xx.xx |
| DOC | DOCTOR CARE ANYWHERE GROUP PLC | $0.12 | $xx.xx | $xx.xx | xx.x | xx.xx |
| EBO | EBOS GROUP LIMITED | $36.16 | $xx.xx | $xx.xx | xx.x | xx.xx |
| EBR | EBR SYSTEMS INC | $1.17 | $xx.xx | $xx.xx | xx.x | xx.xx |
| EGH | EUREKA GROUP HOLDINGS LIMITED | $0.60 | $xx.xx | $xx.xx | xx.x | xx.xx |
| FPH | FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED | $34.69 | $xx.xx | $xx.xx | xx.x | xx.xx |
| GSS | GENETIC SIGNATURES LIMITED | $0.38 | $xx.xx | $xx.xx | xx.x | xx.xx |
| HLS | HEALIUS LIMITED | $0.75 | $xx.xx | $xx.xx | xx.x | xx.xx |
| IDX | INTEGRAL DIAGNOSTICS LIMITED | $2.53 | $xx.xx | $xx.xx | xx.x | xx.xx |
| IME | IMEXHS LIMITED | $0.30 | $xx.xx | $xx.xx | xx.x | xx.xx |
| IMM | IMMUTEP LIMITED | $0.24 | $xx.xx | $xx.xx | xx.x | xx.xx |
| IMR | IMRICOR MEDICAL SYSTEMS INC | $1.55 | $xx.xx | $xx.xx | xx.x | xx.xx |
| INA | INGENIA COMMUNITIES GROUP | $5.49 | $xx.xx | $xx.xx | xx.x | xx.xx |
| IPD | IMPEDIMED LIMITED | $0.04 | $xx.xx | $xx.xx | xx.x | xx.xx |
| LIC | IMPEDIMED LIMITED | $7.09 | $xx.xx | $xx.xx | xx.x | xx.xx |
| M7T | MACH7 TECHNOLOGIES LIMITED | $0.34 | $xx.xx | $xx.xx | xx.x | xx.xx |
| MAP | MICROBA LIFE SCIENCES LIMITED | $0.09 | $xx.xx | $xx.xx | xx.x | xx.xx |
| MDR | MEDADVISOR LIMITED | $0.09 | $xx.xx | $xx.xx | xx.x | xx.xx |
| MPL | MEDIBANK PRIVATE LIMITED | $5.15 | $xx.xx | $xx.xx | xx.x | xx.xx |
| MSB | MESOBLAST LIMITED | $1.84 | $xx.xx | $xx.xx | xx.x | xx.xx |
| MVF | MONASH IVF GROUP LIMITED | $0.72 | $xx.xx | $xx.xx | xx.x | xx.xx |
| MVP | MONASH IVF GROUP LIMITED | $0.55 | $xx.xx | $xx.xx | xx.x | xx.xx |
| MX1 | MICRO-X LIMITED | $0.05 | $xx.xx | $xx.xx | xx.x | xx.xx |
| NAN | NANOSONICS LIMITED | $4.05 | $xx.xx | $xx.xx | xx.x | xx.xx |
| NEU | NEUREN PHARMACEUTICALS LIMITED | $14.25 | $xx.xx | $xx.xx | xx.x | xx.xx |
| NHF | NIB HOLDINGS LIMITED | $7.02 | $xx.xx | $xx.xx | xx.x | xx.xx |
| NUZ | NIB HOLDINGS LIMITED | $0.16 | $xx.xx | $xx.xx | xx.x | xx.xx |
| ONE | ONEVIEW HEALTHCARE PLC | $0.25 | $xx.xx | $xx.xx | xx.x | xx.xx |
| OPT | ONEVIEW HEALTHCARE PLC | $0.60 | $xx.xx | $xx.xx | xx.x | xx.xx |
| PAR | ONEVIEW HEALTHCARE PLC | $0.38 | $xx.xx | $xx.xx | xx.x | xx.xx |
| PER | PERCHERON THERAPEUTICS LIMITED | $0.01 | $xx.xx | $xx.xx | xx.x | xx.xx |
| PGC | PARAGON CARE LIMITED | $0.38 | $xx.xx | $xx.xx | xx.x | xx.xx |
| PME | PRO MEDICUS LIMITED | $281.68 | $xx.xx | $xx.xx | xx.x | xx.xx |
| PNV | POLYNOVO LIMITED | $1.20 | $xx.xx | $xx.xx | xx.x | xx.xx |
| PYC | PYC THERAPEUTICS LIMITED | $1.30 | $xx.xx | $xx.xx | xx.x | xx.xx |
| REG | REGIS HEALTHCARE LIMITED | $7.60 | $xx.xx | $xx.xx | xx.x | xx.xx |
| RHC | RAMSAY HEALTH CARE LIMITED | $37.53 | $xx.xx | $xx.xx | xx.x | xx.xx |
| RMD | RESMED INC | $39.05 | $xx.xx | $xx.xx | xx.x | xx.xx |
| SHL | SONIC HEALTHCARE LIMITED | $26.72 | $xx.xx | $xx.xx | xx.x | xx.xx |
| SNT | SONIC HEALTHCARE LIMITED | $0.05 | $xx.xx | $xx.xx | xx.x | xx.xx |
| TLX | TELIX PHARMACEUTICALS LIMITED | $24.07 | $xx.xx | $xx.xx | xx.x | xx.xx |
| TRJ | TELIX PHARMACEUTICALS LIMITED | $0.73 | $xx.xx | $xx.xx | xx.x | xx.xx |
Previous Stories
Fisher & Paykel Healthcare’s Tariffs Annoyance
Jun 04 2025
A consensus-beating FY25 result from Fisher & Paykel Healthcare was undermined by disappointing FY26 guidance, with tariffs partly to blame
Rudi’s View: CSL & NextDC
May 08 2025
Your Editor attended presentations by CSL and NextDC this week
ResMed’s Margin Expansion & Tariff Exemption
Apr 28 2025
ResMed’s largely in-line third quarter results showcased a rising gross margin, while management also moved to ease market concerns regarding tariffs
SMSFundamentals: Should You Sell Your Home To Buy Your Nursing ‘Home’?
Apr 24 2025
Selling the family home is sometimes the most advantageous decision to make
In Brief: Tariffs, Healthcare & Wealth Platforms
Apr 11 2025
Weekly Broker Wrap: Looking through the market chaos of will he (Trump), won’t he on tariffs, analysts dissect the pros and cons of earnings fundamentals versus share prices
The Significance Of Cosmetique’s ASX Listing
Feb 26 2025
A deep dive into cosmetic surgeries ahead of Cosmetique’s ASX listing in March
Trend Remains Up For Catapult International
Feb 18 2025
Michael Gable of Fairmont Equities sees an ongoing uptrend for shares in Catapult Group International
Behring Margin Outlook Still Main Game For CSL
Feb 13 2025
A weak vaccine result dragged on CSL’s H1 result but analysts focus on an improving plasma product margin and solid growth forecasts in maintaining positive views
ESG Focus: Top ASX Companies, Superbugs & Hydrogen
Feb 07 2025
Addressing challenges and opportunities in meeting the UN Sustainable Development Goals and what ESG characteristics underpin share prices
ResMed Shakes Off GLP-1 Scare
Feb 04 2025
The great obesity drug scare of 2023 is now behind ResMed as evidence in the December quarter suggests GLP-1s are actually a positive for the sleep apnoea industry
Latest News
| 1 |
Australian Broker Call *Extra* Edition – Jul 02, 20251:22 PM - Daily Market Reports |
| 2 |
Technical Views On Nasdaq, ASX200 & Gold11:30 AM - Technicals |
| 3 |
Weekly Update On LICs & LITs – 02-Jul-202511:00 AM - Weekly Reports |
| 4 |
Capstone’s Copper Evolution Continues10:30 AM - Commodities |
| 5 |
Rudi’s View: Dicker Data (Stock In Focus)10:00 AM - Rudi's View |